high_risk_cohort,Eligibile,Treated,Sotrovimab,Molnupiravir,Casirivimab
All,67640,5370,2870,2450,50
imid,42500,2600,1390,1180,20
immunosupression,8870,1020,510,500,10
solid_cancer,7240,790,440,340,10
rare_neurological_conditions,5070,780,390,380,10
solid_organ_transplant,3100,730,440,280,10
haematological_disease,2950,710,380,320,10
liver_disease,2790,270,130,130,NA
renal_disease,2780,700,450,240,10
downs_syndrome,950,120,40,80,NA
sickle_cell_disease,710,50,20,30,NA
hiv_aids,300,170,70,110,NA
